UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000033413 |
|---|---|
| Receipt number | R000038096 |
| Scientific Title | Evaluation of the usefulness of "glycemic control target of elderly diabetic patients" for the prevention of drug induced severe hypoglycemia |
| Date of disclosure of the study information | 2018/07/17 |
| Last modified on | 2018/07/17 13:31:06 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the usefulness of "glycemic control target of elderly diabetic patients" for the prevention of drug induced severe hypoglycemia
Acronym
EUCLID
Scientific Title
Evaluation of the usefulness of "glycemic control target of elderly diabetic patients" for the prevention of drug induced severe hypoglycemia
Scientific Title:Acronym
EUCLID
Region
| Japan |
Condition
Condition
elderly diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In May 2016 "Glycemic control target of elderly diabetes mellitus" was announced by the Joint Committee of the Japan Diabetes Society and the Japan Gerontological Society for improving treatment of the elderly diabetes. We evaluate the adequacy of this target from elderly diabetes cases who were hospitalized with hypoglycemia and had to be hospitalized.
Basic objectives2
Others
Basic objectives -Others
Many diabetic drugs are renal excretion metabolism. We will examine the relationship between renal dysfunction and hypoglycemia.
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
HbA1c at hospitalization
Key secondary outcomes
eGFR at hospitalization
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 65 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Cases of an elderly diabetes patient aged 65 years or older who was hospitalized with hypoglycemic ambulance from January 1, 2008 to April 30, 2014.
Key exclusion criteria
Patients under the age of 65 including minors. Cases in which dementia, ADL decline, complication of infection, and malignant tumor are confirmed from the medical record.
Target sample size
150
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masao Toyoda |
Organization
Tokai University School of Medicine
Division name
Division of Nephrology, Endocrinology and Metabolism
Zip code
Address
143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN
TEL
0463-93-1121
m-toyoda@is.icc.u-tokai.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kanori Iwamatsu |
Organization
Tokai University School of Medicine
Division name
Division of Nephrology, Endocrinology and Metabolism
Zip code
Address
143 Shimokasuya, Isehara, Kanagawa 259-1193, JAPAN
TEL
0463-93-1121
Homepage URL
k-iwamtsu@tsc.u-tokai.ac.jp
Sponsor or person
Institute
Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 07 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 09 | Month | 27 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 09 | Month | 27 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
No intervention, retrospective obs ervation study.
Management information
Registered date
| 2018 | Year | 07 | Month | 17 | Day |
Last modified on
| 2018 | Year | 07 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038096
